Carlson College of Veterinary Medicine

N. Mohagheghpour, Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E., and Young, L. S., “Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes.”, Cellular immunology, vol. 176, no. 1, pp. 82-91, 1997.

L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., “Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”, The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.

L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”, Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.

J. D. Cirillo, Cirillo, S. L., Yan, L., Bermudez, L. E., Falkow, S., and Tompkins, L. S., “Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.”, Infection and immunity, vol. 67, no. 9, pp. 4427-34, 1999.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”, Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., “Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.

L. S. Young and Bermudez, L. E., “Perspective on animal models: chronic intracellular infections.”, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 33 Suppl 3, pp. S221-6, 2001.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.

G. C. Perng, Esmaili, D., Slanina, S. M., Yukht, A., Ghiasi, H., Osorio, N., Mott, K. R., Maguen, B., Jin, L., Nesburn, A. B., and Wechsler, S. L., “Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits.”, Journal of virology, vol. 75, no. 19, pp. 9018-28, 2001.

S. Mukherjee, Petrofsky, M., Yaraei, K., Bermudez, L. E., and Cangelosi, G. A., “The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models.”, The Journal of infectious diseases, vol. 184, no. 11, pp. 1480-4, 2001.

H. M. Moulton, Yoshihara, P. H., Mason, D. H., Iversen, P. L., and Triozzi, P. L., “Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.”, Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 8, no. 7, pp. 2044-51, 2002.

K. R. Magnusson, Nelson, S. Edward, and Young, A. B., “Age-related changes in the protein expression of subunits of the NMDA receptor.”, Brain research. Molecular brain research, vol. 99, no. 1, pp. 40-5, 2002.

H. M. Newman, Yang, R. S. H., and Magnusson, K. R., “Effects of developmental exposure to lead, magnesium and zinc mixtures on spatial learning and expression of NMDA receptor subunit mRNA in Fischer 344 rats.”, Toxicology letters, vol. 126, no. 2, pp. 107-19, 2002.

G. - C. Perng, Maguen, B., Jin, L., Mott, K. R., Osorio, N., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Inman, M., Henderson, G., Jones, C., and Wechsler, S. L., “A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.”, Journal of virology, vol. 76, no. 3, pp. 1224-35, 2002.

G. - C. Perng, Maguen, B., Jin, L., Mott, K. R., Kurylo, J., BenMohamed, L., Yukht, A., Osorio, N., Nesburn, A. B., Henderson, G., Inman, M., Jones, C., and Wechsler, S. L., “A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits.”, Journal of virology, vol. 76, no. 16, pp. 8003-10, 2002.

C. W. Noonan, Reif, J. S., Burch, J. B., Ichinose, T. Y., Yost, M. G., and Magnusson, K. R., “Relationship between amyloid beta protein and melatonin metabolite in a study of electric utility workers.”, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, vol. 44, no. 8, pp. 769-75, 2002.

J. P. Teifke, Kidney, B. A., Löhr, C. V., and Yager, J. A., “Detection of papillomavirus-DNA in mesenchymal tumour cells and not in the hyperplastic epithelium of feline sarcoids.”, Veterinary dermatology, vol. 14, no. 1, pp. 47-56, 2003.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.

L. Bai, Hof, P. R., Standaert, D. G., Xing, Y., Nelson, S. E., Young, A. B., and Magnusson, K. R., “Changes in the expression of the NR2B subunit during aging in macaque monkeys.”, Neurobiology of aging, vol. 25, no. 2, pp. 201-8, 2004.

L. E. Bermudez and Yamazaki, Y., “Effects of macrolides and ketolides on mycobacterial infections.”, Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.

C. M. Whipps, Grossel, G., Adlard, R. D., Yokoyama, H., Bryant, M. S., Munday, B. L., and Kent, M. L., “Phylogeny of the multivalvulidae (Myxozoa: Myxosporea) based on comparative ribosomal DNA sequence analysis.”, J Parasitol, vol. 90, no. 3, pp. 618-22, 2004.

L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.

G. Carter, Young, L. S., and Bermudez, L. E., “A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.”, Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.